Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.
about
Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegansAnimal models of polyglutamine diseases and therapeutic approachesUsing C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseasesLessons learned from the transgenic Huntington's disease ratsHistone methylation restrains the expression of subtype-specific genes during terminal neuronal differentiation in Caenorhabditis elegansThe role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogasterDEG/ENaC but not TRP channels are the major mechanoelectrical transduction channels in a C. elegans nociceptorThe glutaredoxin GLRX-21 functions to prevent selenium-induced oxidative stress in Caenorhabditis elegansProteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis.Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation.Medium- and high-throughput screening of neurotoxicants using C. elegans.Chemical enhancement of torsinA function in cell and animal models of torsion dystonia.Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice.Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.Prion-like proteins sequester and suppress the toxicity of huntingtin exon 1.Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organismsA cellular perspective on conformational disease: the role of genetic background and proteostasis networks.Disrupted-in-Schizophrenia 1-mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signalingDying for a cause: invertebrate genetics takes on human neurodegeneration.Inhibitors of metabolism rescue cell death in Huntington's disease models.Mutations in the pqe-1 gene enhance transgene expression in Caenorhabditis elegansProtein homeostasis in models of aging and age-related conformational disease.Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.Control of nonapoptotic developmental cell death in Caenorhabditis elegans by a polyglutamine-repeat protein.What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?Neurodegenerative disorders: insights from the nematode Caenorhabditis elegansChemistry and the worm: Caenorhabditis elegans as a platform for integrating chemical and biological research.Polyglutamine misfolding in yeast: toxic and protective aggregation.Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration.Animal models of neurodegenerative diseases.Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.Distinct mechanisms of mutant huntingtin toxicity in different yeast strains.A protein polymerization cascade mediates toxicity of non-pathological human huntingtin in yeast.Food-Derived Antioxidant Polysaccharides and Their Pharmacological Potential in Neurodegenerative Diseases.In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model.Non-random-coil behavior as a consequence of extensive PPII structure in the denatured state.Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.Neuronal GPCR controls innate immunity by regulating noncanonical unfolded protein response genesDiscovery of a novel aggregation domain in the huntingtin protein: implications for the mechanisms of Htt aggregation and toxicity.
P2860
Q21144448-C94A9F2F-9EC4-40A6-9F6E-195085777C79Q24655528-27C335BF-A6AE-4D7D-B4B8-C1EAAB069C9AQ26776093-5ECB0626-76E6-4B02-B296-AC16078E2381Q27027178-F39C468B-B31C-4130-92E6-508A817FFF78Q27318351-AA8E7CAE-251A-48E9-A903-9D38BFFE4C7EQ28083445-F7C0276A-1D00-4FD8-8CD3-DB49D2DA831EQ28740511-2D3096C0-48DD-4470-8E3A-C5F6345DE624Q28748302-93FD0923-0F0C-45C9-BB44-3E2621DCFC74Q30418699-FD290F4D-E188-47CC-AAB8-4D49D302B64DQ33292491-C55B0278-F20D-474F-ACAB-F1A882BA174AQ33402686-A68952E0-4576-4A79-B223-4B8FDB4DD433Q33540113-505C1CF2-7C31-40B5-ADEE-D771BB9F8EDFQ33571914-4C570D4F-CCCB-4225-A7F5-91724469A930Q33694463-D20EA3AD-3872-45AF-BB04-BA4113C5CBBEQ33729960-C9FD43D7-182E-473E-A0BE-DAFDBF122CD7Q34082859-30508909-9A6D-424D-A461-C37BAC8023D4Q34158629-368788CC-8382-4E42-9735-026ECE4B9A29Q34631852-F313F8A4-493A-45A7-817F-0739CC7E09DFQ34804747-B3921165-053B-4FD2-B3D9-C8C00E55028CQ35074847-8C505233-B4A3-4268-9EA4-8846A3B1EFD5Q35971716-33449B6A-098B-479D-94F3-DC74F807B1CEQ36065954-9033D350-3845-4FFA-B7C8-038A3F6AD3FAQ36109387-508D46C5-AFC5-42A1-BEDC-02E4BA88CC03Q36927018-C539BD7A-5E7B-45D6-99AF-34915B78DFB5Q37380440-3576D3B1-76AA-47ED-8468-FA7333A19469Q37389590-2F2F285E-097A-40B1-BEE7-97113F8013C6Q37759354-2DEAB150-FE49-4782-80BF-D07206EA7E3EQ37866234-0EFDCC37-3DAE-4B27-B2C3-119154170376Q37952579-8C7386BA-679F-4F35-BDF8-1D8BCFE10008Q38108756-D41569A3-3EE7-4DB8-B014-540A70412F20Q38165759-46DF786F-937B-49AC-8029-DCD53FAB1978Q38253642-08BA01C1-0CC3-4490-B327-DB16FFAF8F47Q39133029-232D8F1B-578D-4F2B-B93A-92F404704781Q40205629-5BE2D84F-348D-4562-9D67-F16B276A16A3Q41195586-E0B4C725-D617-4F18-95D2-603EBEF84FC6Q41497184-2C9C4D6A-EFB3-449E-B44C-BEFC7010C8CFQ42254511-441CE906-E618-40E6-BA2C-24D136B53EE4Q42363775-2C731B12-C09D-4B48-92A7-CF9FA5B1D099Q42778781-967D57C6-C093-48CB-A627-0A21B4C376FCQ43553075-576D2231-9A10-441F-821B-C402E1FD70F2
P2860
Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@ast
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@en
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@nl
type
label
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@ast
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@en
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@nl
prefLabel
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@ast
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@en
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@nl
P2093
P2860
P356
P1476
Glutamine/proline-rich PQE-1 p ...... n polyglutamine neurotoxicity.
@en
P2093
Anne C Hart
Cindy Voisine
Daphne C King
Emily A Bates
Peter W Faber
P2860
P304
17131-17136
P356
10.1073/PNAS.262544899
P407
P577
2002-12-16T00:00:00Z